The Greek pharmaceutical industry is poised for growth as international trends reshape the sector. Over…
Tag: pharmaceutical industry
Greek Pfizer CEO Albert Bourla agreed to lower the cost of prescription drugs for Medicaid…
Greek-American Pfizer CEO Albert Bourla attended a $25 million MAGA Inc. fundraiser at Trump’s Bedminster golf club, following Trump’s demand for lower U.S. drug prices in line with international rates, raising questions about pharmaceutical alignment with his agenda.
From steering global giants like JP Morgan Chase, Costco, Pfizer, and Louis Vuitton, to reshaping industries with figures such as the ‘Queen of Pearls’ in Australia and the ‘Beer Lord’ of Europe, Greek-born CEOs are leading multinational empires. Despite global challenges like inflation, energy costs, and supply chain turmoil, these resilient leaders are writing their own success stories, driven by innovation, ambition, and a fierce competitive spirit. In this feature, we explore the remarkable journeys of ten Greek CEOs who are making history in the international business world.
Mary and Michael Jaharis are celebrated figures within the Greek-American community, known for their profound contributions to both the pharmaceutical industry and philanthropic endeavors. Their legacy includes a significant $50 million donation to The Met and support for the reconstruction of St. Nicholas Church at Ground Zero, epitomizing their dedication to cultural heritage and humanitarian efforts. Mary Jaharis continues to uphold this legacy, reflecting her passion for art, education, and her Greek roots.
Greece is facing a shortage of the diabetes medications Ozempic and Victoza, leading Novo Nordisk to urge cautious prescribing. The company highlights that these drugs should be reserved for patients with type 2 diabetes, warning against their use for weight loss to prevent further strain on limited supplies.
Greece is set to see a significant increase in drug prices this fall, following new pricing adjustments by the Greek National Organization for Medicines (EOF). Among the 850 drugs affected, price hikes range from minor adjustments to increases of up to 448%, with one medication’s cost soaring from 0.96 euros to 5.26 euros.
Ozempic, a prescription drug typically used to treat diabetes, has become increasingly popular as a weight-loss aid among people without diabetes. Despite its potential risks and unknown long-term effects, Ozempic is easily obtainable in some countries without a prescription.
Prime Minister Kyriakos Mitsotakis met on Wednesday with the heads of companies and unions that…
